Cargando…

Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma

BACKGROUND: To improve cure rates for neuroblastoma (NB), it is important and necessary to evaluate therapy response. Our investigation focuses on using plasma cell free DNA (cfDNA) as a biomarker to determine tumor burden and minimal residual disease (MRD) of NB patients during chemotherapy. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Yan, Wang, Lijun, Wang, Xisi, Yue, Zhixia, Xing, Tianyu, Zhao, Wen, Zhao, Qian, Duan, Chao, Huang, Cheng, Han, Yi, Qiu, Lihua, Cheng, Xianfeng, Liu, Yi, Ma, Xiaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488154/ https://www.ncbi.nlm.nih.gov/pubmed/30793512 http://dx.doi.org/10.1002/cam4.2045

Ejemplares similares

Plasma cell‐free DNA quantification is highly correlated to tumor burden in children with neuroblastoma
por: Wang, Xisi, et al.
Publicado: (2018)

Implementation of the plasma MYCN/NAGK ratio to detect MYCN amplification in patients with neuroblastoma
por: Su, Yan, et al.
Publicado: (2020)

Increased plasma concentration of cell-free DNA precedes disease recurrence in children with high-risk neuroblastoma
por: Su, Yan, et al.
Publicado: (2020)

Whole exome sequencing reveals novel somatic alterations in neuroblastoma patients with chemotherapy
por: Duan, Chao, et al.
Publicado: (2018)

Iron deficiency in children at the time of initial neuroblastoma diagnosis
por: Fan, Hongjun, et al.
Publicado: (2019)

Apatinib plus retinoic acid as maintenance for children with relapsed stage 4 high-risk neuroblastoma: Two case reports
por: Jin, Mei, et al.
Publicado: (2020)

Comparison of Survival Benefits of Combined Chemotherapy and Radiotherapy Versus Chemotherapy Alone for Uterine Serous Carcinoma: A Meta-analysis
por: Lin, Yanying, et al.
Publicado: (2017)

TRIM proteins in neuroblastoma
por: Xu, Yonghu, et al.
Publicado: (2019)

γδTFH cells promote B cell maturation and antibody production in neuroblastoma
por: Mou, Wenjun, et al.
Publicado: (2017)

Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma
por: Imaya, Masayuki, et al.
Publicado: (2022)

Treatment of malignant rhabdoid tumors of the head and neck with combined chemotherapy and (125)I particle implantation
por: Duan, Chao, et al.
Publicado: (2018)

Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma
por: Meng, Xinyao, et al.
Publicado: (2020)

Probing of breast cancer using a combination of plasma and urinary circulating cell-free DNA
por: Zuo, Zhigang, et al.
Publicado: (2020)

MIR938 rs2505901 T>C polymorphism is associated with increased neuroblastoma risk in Chinese children
por: Jiang, Susu, et al.
Publicado: (2023)

Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma
por: Maser, Tyler, et al.
Publicado: (2017)

TP53 Arg72Pro polymorphism and neuroblastoma susceptibility in eastern Chinese children: a three-center case–control study
por: Fang, Yuan, et al.
Publicado: (2020)

HOTTIP polymorphism may affect gastric cancer susceptibility by altering HOTTIP expression
por: Wang, Ben-gang, et al.
Publicado: (2020)

Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression
por: Rifatbegovic, Fikret, et al.
Publicado: (2017)

Melatonin promotes neuroblastoma cell differentiation by activating hyaluronan synthase 3‐induced mitophagy
por: Lee, Wen‐Jui, et al.
Publicado: (2019)

MYCN amplification plus 1p36 loss of heterozygosity predicts ultra high risk in bone marrow metastatic neuroblastoma
por: Yue, Zhi‐Xia, et al.
Publicado: (2022)

First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component
por: Zhou, Yu‐Wen, et al.
Publicado: (2021)

Prediction of prognosis of patients with lung cancer in combination with the immune score
por: Han, Ke, et al.
Publicado: (2021)

BPTF in bone marrow provides a potential progression biomarker regulated by TFAP4 through the PI3K/AKT pathway in neuroblastoma
por: Jiang, Chiyi, et al.
Publicado: (2023)

Regarding human cytomegalovirus in neuroblastoma
por: Forslund, Ola, et al.
Publicado: (2014)

Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer
por: Xiong, Ying, et al.
Publicado: (2020)

Poly-amino acids coated gold nanorod and doxorubicin for synergistic photodynamic therapy and chemotherapy in ovarian cancer cells
por: Liu, JinYing, et al.
Publicado: (2019)

Identification of the plasma total cfDNA level before and after chemotherapy as an indicator of the neoadjuvant chemotherapy response in locally advanced breast cancer
por: Ma, Ge, et al.
Publicado: (2020)

Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p/HNF4α axis via RAS/RAF/MEK/ERK signaling pathway in pediatric neuroblastoma cells
por: Deng, Defeng, et al.
Publicado: (2020)

Detection of tumor ALK status in neuroblastoma patients using peripheral blood
por: Combaret, Valérie, et al.
Publicado: (2015)

Alveolar rhabdomyosarcoma with bone marrow metastasis causes disseminated intravascular coagulation
por: Su, Yan, et al.
Publicado: (2019)

Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNA
por: Peng, Muyun, et al.
Publicado: (2019)

Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapy
por: Zhao, Yanding, et al.
Publicado: (2020)

PD-1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in patients with advanced non-squamous non-small-cell lung cancer: a pooled analysis of three randomised trials
por: Meng, Xiangjiao, et al.
Publicado: (2022)

AKR1B10 regulates M2 macrophage polarization to promote the malignant phenotype of gastric cancer
por: Wu, Yi, et al.
Publicado: (2023)

An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

Long noncoding RNA LINC01410 promotes the tumorigenesis of neuroblastoma cells by sponging microRNA‐506‐3p and modulating WEE1
por: Mi, Jie, et al.
Publicado: (2020)

Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma
por: Saulnier Sholler, Giselle L, et al.
Publicado: (2015)

Genetic variation associated with childhood and adult stature and risk of MYCN‐amplified neuroblastoma
por: Semmes, Eleanor C., et al.
Publicado: (2020)

A Comparative Study of Neuroendocrine Heterogeneity in Small Cell Lung Cancer and Neuroblastoma
por: Cai, Ling, et al.
Publicado: (2023)

miR-152/TNS1 axis inhibits non-small cell lung cancer progression through Akt/mTOR/RhoA pathway
por: Duan, Jinjin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a1jvhdgckcnik27nt0dmfbmlq6